Vaginal Estrogen and Recurrent Stroke Risk: Time to Remove FDA Warning?

Vaginal estrogen does not raise recurrent stroke risk in postmenopausal women, bolstering calls from experts to remove the ‘inappropriate’ boxed warning on these products.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/vaginal-estrogen-and-recurrent-stroke-risk-time-remove-fda-2025a1000m7f
via IFTTT

At Least 600 US CDC Employees Are Getting Final Termination Notices, AP Reports

At least 600 employees of the U.S. Centers for Disease Control and Prevention are receiving permanent termination notices, the Associated Press reported on Wednesday, citing…

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/least-600-us-cdc-employees-are-getting-final-termination-2025a1000m1y
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started